when administered by intravenous or intramuscular injection in single or total doses amounting to only 50-70 % of those of bleomycin ( bleocin ) , bleomycetin proved effective in the treatment of extended squamous cell carcinoma of the head and neck , skin , cervix uteri , embryonal cancer of the testicle and , particularly , recurrent hodgkin 's disease and non-hodgkin 's lymphoma .
C0005740
bleomycin
C0024305
non-hodgkin 's lymphoma